Shares of Assembly Biosciences advanced after the company reported encouraging results from a clinical trial of its treatment for the hepatitis B virus. The stock was up 5.2% at $15.49 in premarket ...

Assembly Biosciences, Inc. (ASMB), a biotechnology company, Thursday announced encouraging interim data from Phase 1b study of ...

Assembly Biosciences (ASMB) stock gains on interim data from a Phase 1 trial for its hepatitis B treatment ABI-4334 developed ...

编者按在慢性乙型肝炎（CHB）的治疗领域，追求功能性治愈已逐步成为共识，但这并不意味着放弃对疾病的根治追求。2024年12月20~22日，在首届“井冈星火”消化肝病高峰论坛上，北京大学医学部庄辉院士在会上作了关于“功能性治愈是CHB治疗的主要终点”的 ...

Should RFK Jr. be confirmed as HHS secretary, he will wield power over policy details that could shape the trajectory of U.S.

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing ...

Srinagar- Kashmir's leading tertiary care hospital, Sher-e-Kashmir Institute of Medical Sciences (SKIMS) Soura, has ...

The Russian mRNA vaccine under development can be “personalised” based on the genetic analysis of each person’s tumour to ...

The diagnosis of hepatitis A virus (HAV) infection is based on the detection of anti-HAV IgM. Shortcomings of this serological approach include the persistence of IgM after normalization of liver ...

On Wednesday, Christmas Day, the 1 Division of the Nigerian Army in Kaduna was a beehive of activities as John Asiemo, ...

Mr Turji also blamed the arrest on intelligence provided by the residents of the areas, whom he said would face the ...

Analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for shares of Enanta Pharmaceuticals in a ...